Brevan Howard Capital Management’s Amgen AMGN Stock Holding History

Brevan Howard Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.8M	Buy	5,120 +2,308	+82%	+$823K	0.02%	598
2025 Q4	$921K	Sell	2,812 -1,931	-41%	-$613K	0.01%	805
2025 Q3	$1.34M	Sell	4,743 -13,968	-75%	-$4.05M	0.01%	766
2025 Q2	$5.22M	Sell	18,711 -3,345	-15%	-$948K	0.03%	354
2025 Q1	$6.87M	Buy	+22,056	New	+$6.51M	0.07%	94
2024 Q4	–	Sell	-3,749	Closed	-$1.21M	–	1021
2024 Q3	$1.21M	Buy	+3,749	New	+$1.23M	0.01%	392
2024 Q1	–	Sell	-922	Closed	-$266K	–	992
2023 Q4	$266K	Buy	+922	New	+$251K	﹤0.01%	771

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Brevan Howard Capital Management's AMGN Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Amgen (AMGN) stake by 82% in Q1 2026, buying an estimated $823K and bringing the position to 5,120 shares worth $1.8M. The position accounts for 0.02% of the portfolio, ranked #598.

Brevan Howard Capital Management first reported a position in AMGN in Q4 2023 and has held it in 7 quarters since. The position peaked at $6.87M in Q1 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Brevan Howard Capital Management held 5,120 shares of Amgen worth $1.8M as of Q1 2026.
Brevan Howard Capital Management bought 2,308 Amgen shares in Q1 2026, an estimated $823K.
Amgen made up 0.02% of Brevan Howard Capital Management's portfolio in Q1 2026, its #598 holding.
Brevan Howard Capital Management first reported a position in Amgen in Q4 2023 and has held it in 7 quarters since.
Brevan Howard Capital Management's Amgen position peaked at $6.87M in Q1 2025.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.